Abilify Weight Gain: Lower Than Most Antipsychotics, but Not Zero

You read that Abilify is the “weight-neutral” antipsychotic, so the number on the scale three months in feels like a betrayal. Or maybe your prescriber suggested adding it to your antidepressant, and weight is the first thing you want to understand before saying yes.

Your appetite and metabolism are steered partly by chemical signals in your brain, including histamine, serotonin, and dopamine. Many antipsychotics block receptors for these signals, and an antipsychotic network meta-analysis notes that histamine H1, serotonin 5-HT2A, and muscarinic M3 receptors have been implicated in metabolic side effects. Aripiprazole is built differently. Its FDA prescribing information describes it as a partial agonist at dopamine D2 receptors, with only moderate affinity for histamine H1 and serotonin 5-HT2C receptors and no appreciable affinity for muscarinic receptors. That difference in receptor targeting is a matter of precision, and it shows up in the data.

That same meta-analysis pooled 100 randomized trials with 25,952 patients and found no evidence of weight gain with aripiprazole compared with placebo during acute schizophrenia treatment. Aripiprazole was the only antipsychotic in the analysis that showed either no change or improvement across every metabolic measure, while olanzapine and clozapine had the worst profiles. The results are real, and the science is well established.

But most of those trials lasted about six weeks, and at Siggy we don’t think a six-week average should be the only number you hear before committing to a medication you may take for a year or more.

So this guide pairs the short-term trial results with longer-term data, dose effects, and the groups who tend to gain more. A licensed prescriber can use that fuller picture, along with your own history, to decide whether aripiprazole fits and how to watch for change. That keeps the conversation anchored to how long you’ll actually take it, rather than a single trial snapshot, and it rests on evidence.

What This Page Covers

• How Much Weight Do People Gain on Abilify?
• Why Does Abilify Cause Less Weight Gain Than Other Antipsychotics?
• Does Abilify Weight Gain Get Worse Over Time?
• Is It the Abilify or the Antidepressant?
• Who Is More Likely to Gain Weight on Abilify?
• What Can Help If You Are Gaining Weight?
• What Should You Watch Besides the Scale?
• How Siggy Fits In
• Start Your Anonymous Intake

How Much Weight Do People Gain on Abilify?

The answer changes with who’s taking it, why, and for how long. In the label’s pooled short-term trials in adults, mostly for schizophrenia or bipolar disorder with a median exposure of about three weeks, average weight change was 0.3 kg on aripiprazole versus a 0.1 kg loss on placebo.

When Abilify was added to an antidepressant for six weeks, people gained an average of 1.7 kg versus 0.4 kg on placebo, and 5.2% gained at least 7% of their body weight, compared with 0.6% on placebo. In four- to six-week schizophrenia trials, 8.1% gained that much versus 3.2% on placebo, and in three-week bipolar mania trials the figure was 2.2% versus 2.7%.

Here’s how the numbers shift across settings, drawn from the FDA label and the long-term studies discussed below.

Setting	Length	Average Change	Gained 7% or More
Adults, schizophrenia or bipolar	3 to 6 weeks	+0.3 kg	2.2% to 8.1%
Adults, added to antidepressant	6 weeks	+1.7 kg	5.2%
Adults, added to antidepressant	52 weeks, open-label	+4.4 kg	36.6%
Youth new to antipsychotics	About 11 weeks	+4.4 kg	Not reported

Why Does Abilify Cause Less Weight Gain Than Other Antipsychotics?

The leading explanation is its receptor profile. Weight gain with antipsychotics has been tied to histamine, serotonin, and muscarinic receptors, and aripiprazole has only moderate affinity for histamine H1 and serotonin 5-HT2C receptors and essentially none for muscarinic receptors, according to its label.

Comparison data in young people point the same way. In a JAMA cohort study of children and teens taking an antipsychotic for the first time, average gain over about 11 weeks was 8.5 kg with olanzapine, 6.1 kg with quetiapine, 5.3 kg with risperidone, and 4.4 kg with aripiprazole, compared with 0.2 kg in a small untreated comparison group. Aripiprazole came out lowest, and it still wasn’t zero, although its metabolic lab changes weren’t significant.

If you’re comparing options, our guide to Seroquel weight gain covers quetiapine in more detail.

Does Abilify Weight Gain Get Worse Over Time?

For some people, yes. In a 52-week open-label study of aripiprazole added to antidepressants, average weight gain was 4.4 kg, and 36.6% of people who stayed in the study gained at least 7% of their body weight. Weight gain was reported as a side effect by 17.1% of participants. Only about a third completed the full year, which makes the long-term picture less certain.

Dose may matter. A long-term systematic review found medically significant weight gain in 25% to 28% of people in studies using doses of 5 mg or more, versus 3.5% in a study using doses under 5 mg. All of the included studies were open-label without a control group, so treat that gap as a signal rather than proof.

Not every long-term dataset agrees. A large weight meta-analysis of 307 studies found that almost all antipsychotics caused weight gain with prolonged use, but aripiprazole was one of three with negligible change in a dataset made up mostly of studies where people switched from another antipsychotic. In people new to antipsychotics, weight gain was more pronounced for every drug studied.

Is It the Abilify or the Antidepressant?

Often it’s hard to tell. Most people taking Abilify for depression are also on an antidepressant, and antidepressants can affect weight on their own. Researchers in an adjunctive combination analysis noted that it’s difficult to separate the two contributions and recommended monitoring weight with any combination.

Antidepressants differ from one another, too. A 2024 Annals study of 183,118 patients found measurable differences in six-month weight change across eight common antidepressants, with bupropion linked to the least gain. That’s one reason your prescriber may look at your whole regimen, not just the newest addition.

Who Is More Likely to Gain Weight on Abilify?

A few patterns stand out across the studies above.

• Younger people: in the label’s pediatric schizophrenia and bipolar trials, average gain at 24 weeks was 5.8 kg versus 1.4 kg on placebo, though the placebo group was small.
• People new to antipsychotics: both the JAMA cohort and the 307-study meta-analysis found larger gains in people without prior antipsychotic exposure.
• Higher doses: long-term studies using 5 mg or more reported more significant weight gain than one using lower doses.
• Longer use: average gain in the year-long study was more than double the six-week figure.

Increased appetite was reported by 3% of adults taking adjunctive Abilify versus 2% on placebo in the label’s depression trials. If you notice you’re hungrier, that’s worth mentioning early.

What Can Help If You Are Gaining Weight?

Start with measurement. The Abilify label recommends clinical monitoring of weight, and fasting blood glucose at the start of treatment and periodically for people with diabetes risk factors. A baseline weight before you begin makes later changes easy to spot.

From there, options to discuss with your prescriber include:

• Reviewing the dose, since lower doses may carry less weight gain.
• Adding nutrition and activity support early, before gain builds.
• Considering metformin. A metformin trial meta-analysis of 12 trials found it reduced weight by about 3.3 kg versus placebo in people taking antipsychotics, mostly for schizophrenia.
• Weighing whether aripiprazole is still the best fit for your goals.

Don’t stop Abilify on your own. Your symptoms can return, and any change works best when it’s planned with your prescriber.

What Should You Watch Besides the Scale?

Weight isn’t the only metabolic signal. In the label’s adjunctive depression trials, fasting triglycerides moved from normal to high in 9.7% of people on Abilify versus 4.1% on placebo, while average fasting glucose didn’t differ from placebo. Ask whether periodic lipid and glucose checks make sense for you.

Restlessness matters too. Akathisia, an inner urge to keep moving, was reported by 25% of people taking adjunctive Abilify versus 4% on placebo. Our guide to Abilify side effects explains akathisia and the label’s other warnings, and how long Abilify takes to work covers the timeline.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions. If Abilify is already part of your treatment or being discussed as an add-on, Siggy’s free, anonymous intake lets you share your full medication list, your weight history, and concerns like diabetes in your family. The intake gathers structured information and doesn’t diagnose you on its own. A licensed prescriber reviews it before anything is prescribed.

A common frustration in care is that “no one checks in to see if it’s actually working,” and the same gap applies to side effects like weight. You get a downloadable summary you can share with your primary care clinician for weight and lab monitoring. Siggy isn’t an emergency service. If you’re having thoughts of harming yourself, call 911 or call or text 988. This article is for education and isn’t a substitute for advice from your own prescriber. It reflects sources available as of November 2026.

Start Your Anonymous Intake

Abilify’s reputation as a low-weight-gain antipsychotic holds up in short trials, but a year of use, a higher dose, or a younger age can change the picture. Knowing your baseline, checking regularly, and having someone to talk to when the numbers move all help you catch changes early. Start your anonymous intake with Siggy to share your medications and concerns without giving your name or email. It’s free, a licensed prescriber reviews your full picture before anything is prescribed, and your summary is yours to keep.